Growth Metrics

Health Catalyst (HCAT) Short-term Investments (2018 - 2025)

Health Catalyst's Short-term Investments history spans 8 years, with the latest figure at $44.9 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 68.45% year-over-year to $44.9 million; the TTM value through Dec 2025 reached $44.9 million, down 68.45%, while the annual FY2025 figure was $44.9 million, 68.45% down from the prior year.
  • Short-term Investments reached $44.9 million in Q4 2025 per HCAT's latest filing, down from $51.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $255.9 million in Q3 2022 to a low of $44.9 million in Q4 2025.
  • Average Short-term Investments over 5 years is $161.7 million, with a median of $179.4 million recorded in 2021.
  • Peak YoY movement for Short-term Investments: plummeted 76.84% in 2021, then skyrocketed 292.58% in 2022.
  • A 5-year view of Short-term Investments shows it stood at $251.8 million in 2021, then fell by 1.82% to $247.2 million in 2022, then fell by 14.45% to $211.5 million in 2023, then tumbled by 32.68% to $142.4 million in 2024, then plummeted by 68.45% to $44.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Short-term Investments are $44.9 million (Q4 2025), $51.2 million (Q3 2025), and $46.6 million (Q2 2025).